SEC Form 4 · accession 0001123292-17-000299
VIVUS INC · VVUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Santosh T Varghese
Officer — Chief Medical Officer
Period of report
Jan 27, 2017
Accepted (ET)
Jan 31, 2017 · 6:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000881524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 28, 2017 | S | 429 | $1.1101 | D | 74,037 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $1.12 | Jan 27, 2017 | A | 385,000 | A | — | Jan 27, 2024 | Common Stock | 385,000 | 385,000 | D |
Explanation of responses
- F1Sold to pay the tax liability resulting from the vesting of 925 restricted stock units granted on January 28, 2014.
- F2Twenty-five percent (25%) of the total number of shares underlying the option will vest and become exercisable on January 27, 2018, and one forty-eighth (1/48th) of the total number of shares underlying the option will vest on the 27th of each month thereafter, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2010 Equity Incentive Plan) on the relevant vesting dates.